Works matching IS 11738804 AND DT 2006 AND VI 20 AND IP 2
Results: 7
Spotlight on Gemtuzumab Ozogamicin in Acute Myeloid Leukaemia1.
- Published in:
- BioDrugs, 2006, v. 20, n. 2, p. 137, doi. 10.2165/00063030-200620020-00007
- By:
- Publication type:
- Article
Peroxisome Proliferator-Activated Receptor-γ: Novel Therapeutic Target Linking Adiposity, Insulin Resistance, and Atherosclerosis.
- Published in:
- BioDrugs, 2006, v. 20, n. 2, p. 121, doi. 10.2165/00063030-200620020-00006
- By:
- Publication type:
- Article
Neuroproteases in Peptide Neurotransmission and Neurodegenerative Diseases: Applications to Drug Discovery Research.
- Published in:
- BioDrugs, 2006, v. 20, n. 2, p. 105, doi. 10.2165/00063030-200620020-00005
- By:
- Publication type:
- Article
Cytokine and Anti-Cytokine Therapies for Psoriasis and Atopic Dermatitis.
- Published in:
- BioDrugs, 2006, v. 20, n. 2, p. 93, doi. 10.2165/00063030-200620020-00004
- By:
- Publication type:
- Article
Efficacy of Alemtuzumab in Organ Transplantation: Current Clinical Status.
- Published in:
- BioDrugs, 2006, v. 20, n. 2, p. 85, doi. 10.2165/00063030-200620020-00003
- By:
- Publication type:
- Article
Immunostimulants Revisited: Focus on the Pharmacology of Ribomunyl®.
- Published in:
- BioDrugs, 2006, v. 20, n. 2, p. 81
- By:
- Publication type:
- Article
Orphan Drug Designation and Pharmacogenomics: Options and Opportunities.
- Published in:
- BioDrugs, 2006, v. 20, n. 2, p. 71, doi. 10.2165/00063030-200620020-00001
- By:
- Publication type:
- Article